PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-0.43%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-2.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
9.72%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
10.53%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.71%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.21%
Dividend growth at 50-75% of NXPI's 0.29%. Martin Whitman would question if the firm lags in returning cash to shareholders.
-51.48%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-56.63%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
37.56%
10Y revenue/share CAGR 1.25-1.5x NXPI's 33.39%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
18.56%
5Y revenue/share CAGR 1.25-1.5x NXPI's 14.47%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
4.90%
3Y revenue/share CAGR under 50% of NXPI's 9.84%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
58.74%
10Y OCF/share CAGR under 50% of NXPI's 2724.65%. Michael Burry would worry about a persistent underperformance in cash creation.
56.76%
5Y OCF/share CAGR above 1.5x NXPI's 15.61%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
14.75%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
136.30%
Net income/share CAGR 1.25-1.5x NXPI's 95.32%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
100.76%
5Y net income/share CAGR 1.25-1.5x NXPI's 83.69%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
26.23%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
4.46%
Below 50% of NXPI's 1033.47%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-16.33%
Negative 5Y equity/share growth while NXPI is at 1550.20%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-22.07%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
647.52%
Dividend/share CAGR of 647.52% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
165.01%
Dividend/share CAGR of 165.01% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
80.30%
3Y dividend/share CAGR of 80.30% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
22.53%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.10%
Inventory shrinking or stable vs. NXPI's 2.94%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-4.08%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-12.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
6.76%
Debt growth far above NXPI's 0.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.33%
Our R&D shrinks while NXPI invests at 0.24%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.21%
SG&A declining or stable vs. NXPI's 3.56%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.